Literature DB >> 29549726

Cav-1 deficiency promotes liver fibrosis in carbon tetrachloride (CCl4)-induced mice by regulation of oxidative stress and inflammation responses.

De-Gang Ji1, Yan Zhang2, Song-Mei Yao3, Xu-Jie Zhai4, Li-Rong Zhang5, Yao-Zhong Zhang6, Hui Li7.   

Abstract

Caveolin-1 (Cav-1), as a membrane protein involved in the formation of caveolae, binds steroid receptors and endothelial nitric oxide synthase, limiting its translocation and activation. In the present study, we investigated the role of Cav-1 in the progression of hepatic fibrosis induced by carbon tetrachloride (CCl4) in murine animals. Therefore, the wild type (WT) and Cav-1-knockout (Cav-1-/-) mice were used in our study and subjected to CCl4. The results indicated that CCl4 induced the decrease of Cav-1 expression in liver tissue samples. And Cav-1-/- intensified CCl4-triggered hepatic injury, evidenced by the stronger hepatic histological alterations, serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels and liver terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive cells. CCl4 led to oxidative stress, supported by the reduced superoxide dismutase (SOD) activity and glutathione (GSH) levels, as well as enhanced malondialdehyde (MDA) and O2- levels in liver samples. And the process was intensified by Cav-1-/-. Additionally, CCl4-caused hepatic inflammation was aggregated by Cav-1-/- via further increasing the secretion of pro-inflammatory cytokines. Moreover, CCl4-caused fibrosis was strengthened by Cav-1-/-, which was evidenced by the up-regulation of α-smooth muscle actin (α-SMA), collagen alpha 1 type 1 (Col1A1), lysyl oxidase (Lox) and transforming growth factor-β1 (TGF-β1) in liver tissues. Similar results were observed in TGF-β1-stimulated hepatic stellate cells (HSCs) and LX-2 cells without Cav-1 expressions that in vitro, suppressing Cav-1 further accelerated TGF-β1-induced oxidative stress, inflammation and fibrosis development. In conclusion, our results indicated that Cav-1 played an important role in CCl4-induced hepatic injury, which may be used as potential therapeutic target for hepatic fibrosis treatment.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Cav-1; Hepatic fibrosis; Inflammation; Oxidative stress

Mesh:

Substances:

Year:  2018        PMID: 29549726     DOI: 10.1016/j.biopha.2018.03.016

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  Positive feedback in Cav-1-ROS signalling in PSCs mediates metabolic coupling between PSCs and tumour cells.

Authors:  Shan Shao; Tao Qin; Weikun Qian; Yangyang Yue; Ying Xiao; Xuqi Li; Dong Zhang; Zheng Wang; Qingyong Ma; Jianjun Lei
Journal:  J Cell Mol Med       Date:  2020-07-07       Impact factor: 5.310

Review 2.  Molecular regulation and clinical significance of caveolin-1 methylation in chronic lung diseases.

Authors:  Furong Yan; Lili Su; Xiaoyang Chen; Xiangdong Wang; Hongzhi Gao; Yiming Zeng
Journal:  Clin Transl Med       Date:  2020-04-16

3.  Acute Liver Toxicity Modifies Protein Expression of Glutamate Transporters in Liver and Cerebellar Tissue.

Authors:  Catya Jiménez-Torres; Hoda El-Kehdy; Luisa C Hernández-Kelly; Etienne Sokal; Arturo Ortega; Mustapha Najimi
Journal:  Front Neurosci       Date:  2021-01-06       Impact factor: 4.677

4.  lncRNA NONRATT013819.2 promotes transforming growth factor-β1-induced myofibroblastic transition of hepatic stellate cells by miR24-3p/lox.

Authors:  Can-Jie Guo; Qin Pan; Xiong Ma
Journal:  Open Med (Wars)       Date:  2022-04-04

5.  Caveolin-1 Scaffolding Domain Peptides Alleviate Liver Fibrosis by Inhibiting TGF-β1/Smad Signaling in Mice.

Authors:  Jing Lu; Jie Zhang; Yan Wang; Quan Sun
Journal:  Int J Mol Sci       Date:  2018-06-11       Impact factor: 5.923

Review 6.  TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019.

Authors:  Bedair Dewidar; Christoph Meyer; Steven Dooley; And Nadja Meindl-Beinker
Journal:  Cells       Date:  2019-11-11       Impact factor: 6.600

Review 7.  Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease.

Authors:  Shilu Luo; Ming Yang; Hao Zhao; Yachun Han; Na Jiang; Jinfei Yang; Wei Chen; Chenrui Li; Yan Liu; Chanyue Zhao; Lin Sun
Journal:  Front Pharmacol       Date:  2021-12-10       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.